Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.990
+0.010 (0.34%)
At close: Aug 1, 2025, 4:00 PM
2.970
-0.020 (-0.67%)
After-hours: Aug 1, 2025, 7:34 PM EDT

Company Description

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; and Pediacyn, an atopic dermatitis hydrogel.

The company also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product.

In addition, it offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes, post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, a solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns, a disinfectant; and Endocyn, a root canal irrigation solution.

The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016.

Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado.

Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals logo
CountryUnited States
Founded1999
IPO DateJan 25, 2007
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8
CEOAmy Trombly

Contact Details

Address:
5445 Conestoga Court, Suite 150
Boulder, Colorado 80301
United States
Phone800 759 9305
Websitesonomapharma.com

Stock Details

Ticker SymbolSNOA
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0001367083
CUSIP Number83558L303
ISIN NumberUS83558L3033
Employer ID68-0423298
SIC Code3841

Key Executives

NamePosition
Amy M. Trombly Esq., J.D.Chief Executive Officer, President and Director
Jerome J. Dvonch C.P.A.Chief Financial Officer
Bruce ThorntonExecutive Vice President, Chief Operating Officer and Corporate Secretary
John Dal PoggettoController

Latest SEC Filings

DateTypeTitle
Jul 11, 2025DEF 14AOther definitive proxy statements
Jun 17, 2025S-8Securities to be offered to employees in employee benefit plans
Jun 17, 202510-KAnnual Report
Apr 28, 20258-KCurrent Report
Apr 7, 20258-KCurrent Report
Mar 25, 20258-KCurrent Report
Feb 5, 202510-QQuarterly Report
Jan 30, 20258-KCurrent Report
Jan 3, 20258-KCurrent Report
Jan 3, 2025144Filing